PuraPharm Corporation Limited

HKEX:1498.HK

0.66 (HKD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Operating Activities:
Net Income -18.686-68.406-37.675-80.311-39.903-133.85111.97420.27311.437-182.078-45.187.45813.348-7.2499.13823.8778.28536.054-7.59627.9876.4768.616
Depreciation & Amortization 21.69627.20721.38420.35328.30821.88928.2522.63424.99235.19431.56120.48615.10814.17510.6037.3217.9565.4617.5396.5586.7613.397
Deferred Income Tax 0-33.9836.072-21.13425.724-64.225-70.577-61.176-21.924-11.5650.319-0.5626.00212.27234.5940000000
Stock Based Compensation 0.7252.1442.1470.1020.1660.982.5242.9842.6573.221.0030.7781.3362.0690.1570000000
Change In Working Capital 27.8443.02618.99327.02954.143-75.72-37.52112.8517.35554.6949.03-23.8890.033-17.881-77.82-108.123-50.794-54.132-7.635-8.267-40.452-8.412
Accounts Receivables 18.5450.71652.20617.79983.485-26.402-17.535.732.2334.79443.885-28.361-27.98351.165-18.452-91.8325.992-67.578.272-3.3910.1230
Change In Inventory 27.03422.024-11.858.333-17.04415.87619.59913.52325.92819.03814.35828.14520.645-65.506-16.299-50.114-19.693-4.329-17.34-3.33-21.234-6.141
Change In Accounts Payables -4.471-0.16510.631-6.45816.065-8.941-13.622-32.1772.55638.2116.2010000000011.7942.2710
Other Working Capital -17.73920.451-31.9947.355-28.363-56.253-25.96825.775-23.362-7.353-15.414-23.6737.371-3.54-43.06933.823-37.09317.7671.433-1.546-19.341-2.271
Other Non Cash Items 11.5572.5280.53858.75-7.379200.29276.65838.79225.807156.6219.1223.00814.79547.61-23.55461.372-5.72210.638-2.8995.30926.7194.172
Operating Cash Flow 43.12542.51611.4594.78961.059-50.63511.30836.35850.32456.08245.85327.84144.6238.724-81.476-15.553-40.275-1.979-10.59131.587-0.4967.773
Investing Activities:
Investments In Property Plant And Equipment -0.875-17.226-4.435-8.748-12.92127.332-33.891-52.656-23.391-57.861-39.098-14.67-30.522-66.192-35.436-19.652-21.632-18.206-10.209-7.126-1.46-2.836
Acquisitions Net 0-0.0010.001-0.8120.9082.89100.6010.076-0.1280.12800-12.124-149.6180000000
Purchases Of Investments 00-0.63-1.98400000-1.043-7.95700000000-0.75700
Sales Maturities Of Investments 004.998-1.88900000-035.09900000000000
Other Investing Activites -5.825.978-4.9980.0017.9988.6740.424-23.0616.99830.613-35.099-1.39410.498-26.652-3.079-5.431-18.493-1.906-14.439-19.9873.9392.836
Investing Cash Flow -6.695-17.227-5.064-13.432-12.01330.223-33.891-58.854-23.315-28.419-46.927-16.064-20.024-104.968-188.133-25.083-40.125-20.112-24.648-27.1132.479-6.26
Financing Activities:
Debt Repayment 0000000000000000000000
Common Stock Issued 00000.80300098.048-0.361000000121.10084.0947.57.5
Common Stock Repurchased 000000000000000-2.644-7.37500000
Dividends Paid 00000000000000-4.9420-19.93600000
Other Financing Activities -16.8450.354-0.354-5.7015.7016.172-20.4512.4769.605-16.9034.2259.67437.437-10.069-7.03923.261-4.594262.4575.342.481-2.7468.38
Financing Cash Flow -32.422-61.169-35.58868.755-81.6928.3660.40632.199-2.641.587-51.5689.674-37.698-10.069214.24820.61782.084262.4575.342.481-2.74-68.38
Other Information:
Effect Of Forex Changes On Cash -1.3050.4784.802-9.6464.142.9083.34-4.725.97-2.4611.881-6.4981.866.4682.882-3.396-1.383-8.606-0.293-0.175-0.387-0.195
Net Change In Cash -24.392-35.402-24.39150.466-28.506-15.608-25.79510.00323.3353.369-50.76114.953-11.242-69.845-52.479-23.4150.301231.76-30.19234.16617.6351.409
Cash At End Of Period 22.82947.22182.623107.01456.54885.054100.662126.457116.45493.12474.36790.51675.56386.805156.65209.129232.544232.2430.48358.06123.8957.669